Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
BE PHARMACEUTICALS AG

BE PHARMACEUTICALS AG Recalls

All product recalls associated with BE PHARMACEUTICALS AG.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jan 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–2 of 2 recalls

Fosaprepitant Injection (BE Pharmaceuticals) – Sterility Failure (2024)

Lack of Sterility Assurance: Aseptic process simulation failure.

Class IIModerate

FDAJan 10, 2024Nationwide• BE PHARMACEUTICALS AG

Pantoprazole Sodium Injection (BE Pharmaceuticals) – Sterility Concern (2023)

Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

Class IIModerate

FDASep 5, 2023Nationwide• BE PHARMACEUTICALS AG